Symbion Research International, Inc., was founded in 1995, with the principal purpose of providing superior client-individualized contract research services to biotechnology, pharmaceutical, and device companies. Symbion is a full-service contract research organization (CRO), offering a complete spectrum of strategic and product development, clinical research, and regulatory services to U.S. and international clients. In addition, Symbion provides central imaging review and management as well as a clinical research unit that specializes in conducting Phase I-IIa clinical trials for adult and pediatric populations. We are a value-driven company committed to making a real difference.

Our mission at Symbion is to provide exceptional value to our clients by enabling them to accelerate their product development cycle. We accomplish this by providing high-quality, cost-effective, customized, innovative, and timely strategic planning, preclinical, regulatory, and clinical research services. The Symbion philosophy always is to become a true partner in development, assimilating the client's goals and making the distinction between Symbion and each client as transparent as possible.